• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Introduction to 3-chloro-1H-Indole-6-carboxylic acid (CAS No: 219508-17-5)

3-chloro-1H-Indole-6-carboxylic acid, identified by the Chemical Abstracts Service registry number CAS No219508-17-5, is a significant compound in the realm of organic chemistry and pharmaceutical research. This heterocyclic aromatic acid features a chlorinated indole core, making it a valuable intermediate in the synthesis of various biologically active molecules. The structural motif of indole, combined with the electron-withdrawing effect of the carboxylic acid and the electron-donating nature of the chlorine substituent, endows this compound with unique reactivity and potential applications in medicinal chemistry.

The indole scaffold is widely recognized for its presence in numerous natural products and pharmacologically relevant compounds. Its aromatic system contributes to stability, while the nitrogen atom allows for diverse functionalization possibilities. In particular, 3-chloro-1H-Indole-6-carboxylic acid has garnered attention due to its role as a precursor in the development of novel therapeutic agents. The chloro group at the 3-position enhances electrophilicity, facilitating further derivatization, whereas the carboxylic acid moiety can participate in amide bond formation or other conjugation reactions.

Recent advancements in drug discovery have highlighted the importance of indole derivatives in addressing various diseases, including cancer, infectious disorders, and neurological conditions. The structural versatility of 3-chloro-1H-Indole-6-carboxylic acid allows chemists to modulate its properties by introducing additional functional groups or by exploring different synthetic pathways. For instance, researchers have utilized this compound to develop inhibitors targeting specific enzymatic pathways implicated in disease progression.

In the context of oncology research, 3-chloro-1H-Indole-6-carboxylic acid has been investigated as a building block for small-molecule inhibitors of kinases and other protein targets involved in tumor growth and metastasis. The chloro-substituted indole ring provides a scaffold that can be optimized for high binding affinity and selectivity. Studies have demonstrated that derivatives of this compound exhibit promising antiproliferative effects in vitro, making them candidates for further preclinical evaluation.

Beyond its applications in anticancer therapy, 3-chloro-1H-Indole-6-carboxylic acid has also been explored in the treatment of microbial infections. The indole moiety is known to interact with bacterial biofilms and virulence factors, suggesting potential utility in combating resistant strains. Additionally, modifications to the carboxylic acid group have led to compounds with enhanced antimicrobial activity against Gram-positive and Gram-negative bacteria.

The synthesis of 3-chloro-1H-Indole-6-carboxylic acid typically involves multi-step organic transformations starting from commercially available precursors such as tryptophan or indole derivatives. Key synthetic strategies include chlorination at the 3-position followed by carboxylation at the 6-position. Advances in catalytic methods have improved both yield and efficiency, enabling scalable production for research purposes.

From a computational chemistry perspective, virtual screening techniques have been employed to identify novel derivatives of 3-chloro-1H-Indole-6-carboxylic acid with enhanced pharmacological properties. Molecular docking studies suggest that structural modifications can fine-tune interactions with biological targets, leading to improved drug-like characteristics such as solubility, bioavailability, and metabolic stability.

The growing interest in 3-chloro-1H-Indole-6-carboxylic acid underscores its significance as a versatile intermediate in synthetic chemistry. As research continues to uncover new therapeutic opportunities, this compound is likely to remain a cornerstone in medicinal chemical innovation. Its unique structural features offer a rich palette for designing molecules with tailored biological activities, driving progress across multiple therapeutic areas.

• 1224699-05-1(3-chloro-1H-Indole-5-carboxylic acid)
• 49713-58-8(4-Chloroquinoline-7-carboxylic acid)
• 13337-66-1(7-Chloroquinoline-4-carboxylic acid)
• 62482-32-0(5-Chloroquinoline-4-carboxylic acid)
• 588688-45-3(7-Chloro-1H-indole-4-carboxylic acid)
• 885520-25-2(4-Chloro-1H-indole-6-carboxylic acid)
• 116482-50-9(3-chloro-1H-Indole-6-carboxylic acid methyl ester)
• 42595-25-5(3-Chloro-9-acridinecarboxylic Acid)
• 121490-68-4(8-Chloroquinoline-5-carboxylic acid)
• 386207-77-8(4-Chloroquinoline-6-carboxylic acid)